PD L1 POSITIVE METASTATIC NSCLC

Clinical trials for PD L1 POSITIVE METASTATIC NSCLC explained in plain language.

Never miss a new study

Get alerted when new PD L1 POSITIVE METASTATIC NSCLC trials appear

Sign up with your email to follow new studies for PD L1 POSITIVE METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat lung cancer: experimental combo enters final testing

Disease control Ongoing

This trial is testing whether a new drug called acasunlimab, when combined with pembrolizumab, works better than standard chemotherapy (docetaxel) for people with advanced non-small cell lung cancer. It is for patients whose cancer has spread, is PD-L1 positive, and has gotten wo…

Matched conditions: PD L1 POSITIVE METASTATIC NSCLC

Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

PD L1 POSITIVE METASTATIC NSCLC

Get alerted when new PD L1 POSITIVE METASTATIC NSCLC trials appear

New hope for Tough-to-Treat lung cancer: experimental combo enters final testing